Gajda et al., 2020 - Google Patents
Combinatory treatment with miR-7-5p and drug-loaded cubosomes effectively impairs cancer cellsGajda et al., 2020
View HTML- Document ID
- 17550282571626725128
- Author
- Gajda E
- Godlewska M
- Mariak Z
- Nazaruk E
- Gawel D
- Publication year
- Publication venue
- International journal of molecular sciences
External Links
Snippet
Background: Multidrug resistance (MDR) is an emerging problem in the treatment of cancer. Therefore, there is a necessity for novel strategies that would sensitize tumor cells to the administered chemotherapeutics. One of the innovative approaches in fighting drug …
- 239000003814 drug 0 title abstract description 88
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gajda et al. | Combinatory treatment with miR-7-5p and drug-loaded cubosomes effectively impairs cancer cells | |
| Ramos et al. | Battling chemoresistance in cancer: root causes and strategies to uproot them | |
| Hattinger et al. | Drug resistance in osteosarcoma: emerging biomarkers, therapeutic targets and treatment strategies | |
| Rugamba et al. | Silibinin regulates tumor progression and tumorsphere formation by suppressing PD-L1 expression in non-small cell lung cancer (NSCLC) cells | |
| Pollutri et al. | TP53/MicroRNA interplay in hepatocellular carcinoma | |
| C. de SL Oliveira et al. | Effect of oxaliplatin-loaded poly (d, l-Lactide-co-Glycolic Acid)(PLGA) nanoparticles combined with retinoic acid and cholesterol on apoptosis, drug resistance, and metastasis factors of colorectal cancer | |
| Eid et al. | Targeting cancer stem cells as the key driver of carcinogenesis and therapeutic resistance | |
| Ambrosio et al. | Carbosilane dendrimers loaded with siRNA targeting Nrf2 as a tool to overcome cisplatin chemoresistance in bladder cancer cells | |
| Zhang et al. | The miRNA-21-5p payload in exosomes from M2 macrophages drives tumor cell aggression via PTEN/Akt signaling in renal cell carcinoma | |
| Bahar et al. | Establishment of acquired cisplatin resistance in ovarian cancer cell lines characterized by enriched metastatic properties with increased twist expression | |
| Doan et al. | Glioblastoma multiforme stem cell cycle arrest by alkylaminophenol through the modulation of EGFR and CSC signaling pathways | |
| Scherr et al. | Knockdown of Atg7 induces nuclear-LC3 dependent apoptosis and augments chemotherapy in colorectal cancer cells | |
| Zhang et al. | Carbon dioxide-derived biodegradable and cationic polycarbonates as a new siRNA carrier for gene therapy in pancreatic cancer | |
| Gajda et al. | The role of miRNA-7 in the biology of cancer and modulation of drug resistance | |
| Yang et al. | Inhibition of miR-214-3p aids in preventing epithelial ovarian cancer malignancy by increasing the expression of LHX6 | |
| Pengnam et al. | Synergistic effect of doxorubicin and sirna-mediated silencing of mcl-1 using cationic niosomes against 3d mcf-7 spheroids | |
| Kim et al. | MiR-1208 increases the sensitivity to cisplatin by targeting TBCK in renal cancer cells | |
| Ke et al. | Cyclodextrin-based hybrid polymeric complex to overcome dual drug resistance mechanisms for cancer therapy | |
| Kang et al. | Metformin and niclosamide synergistically suppress Wnt and YAP in APC-mutated colorectal cancer | |
| Panvongsa et al. | More than a bubble: Extracellular vesicle microRNAs in head and neck squamous cell carcinoma | |
| Kucheryavykh et al. | Targeted delivery of nanoparticulate cytochrome C into glioma cells through the proton-coupled folate transporter | |
| Kon et al. | Resveratrol enhances mRNA and siRNA lipid nanoparticles primary CLL cell transfection | |
| Liu et al. | Targeted co-delivery of gefitinib and rapamycin by aptamer-modified nanoparticles overcomes EGFR-TKI resistance in NSCLC via promoting autophagy | |
| Gote et al. | Octreotide-Targeted Lcn2 siRNA PEGylated liposomes as a treatment for metastatic breast cancer | |
| Cai et al. | LncRNA SNHG1 facilitates Tumor Proliferation and represses apoptosis by regulating PPARγ ubiquitination in bladder Cancer |